8 regulation of miscellaneous products Flashcards

1
Q

what is the summary of this lecture?

A

-veterinary pharmaceuticals
-natural health products
-cosmetics
-medical devices
-novel foods
-food additives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the evidence needed for veterinary pharmaceuticals?

A

a veterinary drug is approved for sale in Canada is the manufacturer has supplied evidence that the drug:
-is safe for the animals being treated
-is effective treating the condition for which it is marketed
-is manufactured according to strict specifications
-will not pose demonstrable health hazard to humans eating food products from treated animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the regulatory agencies of veterinary pharmaceuticals?

A

Veterinary Drugs Directorate (VDD), Health Canada
-food and drugs act and regulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is extra-label drug use (ELDU) in animals (“off-label use”)?

A

-the use or intended use of a drug approved by Health Canada in an animal in a manner not in accordance with the label or package insert
-it also includes the use of all unapproved drugs, including unapproved bulk active pharmaceutical ingredients (APIs) and compounded drugs
-VDD acknowledges that ELDU is an important tool in the practice of veterinary medicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the decisions to use ELDU?

A

-a potential lack of efficacy of approved products
-lack of approved products to address specific needs
-economic considerations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the possible human health risks relating to ELDU in animals?

A

-development of antimicrobial resistance (AMR)
-presence of drug residue in foods derived from treated animals and in the environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is antimicrobial resistance (AMR)?

A

-antimicrobials are the most effective treatment for infectious diseases
-AMR is a natural microbial survival mechanism; however, the overuse and misuses of antimicrobials has increased the rate of resistance development and spread
-many available antimicrobials are now less effective for treating disease
-AMR is an emerging global health issue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how many people in canada have AMR?

A

-there has been an 8-fold increase in the rate of methicillin resistance Staphylococcus aureus (MRSA) infections among hospitalized patients in canada from 1995-2012
-each year in canada, more than 18,000 hospitalized patients acquire infections that are resistant to antimicrobials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the categories of antimicrobials?

A

-the antimicrobials in Category 1: essential for the treatment of serious bacterial infections and there are limited or no availability of alternative antimicrobials in case of resistance to these antimicrobials
-Health Canada is recommending against Category 1 antimicrobials use in an ELDU manner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are maximum residue limits (MRLs)?

A

-level of residue that could safely remain in the tissue or food product derived from a food-producing animal that has been treated with a veterinary drug
-no adverse health effects if ingested daily by humans over a lifetime
-veterinary Drugs Directorate (HC) conducts extensive reviews of data submitted by manufacturers to determine whether these veterinary drug residues are at safe levels for human consumption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the list of MRLs for veterinary drugs in foods?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does it mean when there is no MRL required?

A

-low toxicity drug, poorly absorbed or bioavailable, rapidly metabolized or eliminated, likely infrequently used, etc
-no need to routinely monitor the residues of these veterinary drugs in specific foods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the health risk assessment process to establish MRLs?

A

metabolism studies of veterinary drugs conducted in the food-producing animals (e.g. swine, chickens, cows, etc) are reviewed
-concentration and half-life of a drug and its metabolites

comparative metabolism studies conducted in laboratory test animals are reviewed
-similar metabolism pattern?

toxicity of the substance is determined by toxicity/carcinogenicity (cancer) testing
-used to determine Acceptable Daily Intake (ADI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what else is involved in the health risk assessment process to establish MRLs?

A

-a marker residue is identified for the purpose of drug analysis, and an analytical method is developed
-withdrawal period: residue depletion data for the marker residue in the target tissue (highest concentration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are do the labels contain on veterinary drugs (MRLs)?

A

-must include WARNING statements that highlight the human safety related issues on its use
-withdrawal periods for tissues or withholding times for milk
-in a food producing animal, the specified withdrawal period of the withholding time must be observed before the animal is slaughtered or the milk is harvested for use as food to allow the residues to deplete below the MRL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the adverse veterinary drug reactions?

A

-any unwanted or harmful event that occurs that administration of a veterinary drug (according to the label and/or off-label)

all suspected adverse effects should be reported, essentially:
-unexpected (not consistent with product information or labelling)
-serious, whether expected or not (even if listed, need to report)

-anyone can report suspected veterinary drugs adverse reactions to Health Canada
-according to the Food and Drug Regulations (canada), reporting is mandatory for manufacturers

17
Q

what is the job of the veterinary pharmacovigilance program?

A

to monitor:
-the safety and efficacy of veterinary drugs used in animals
-the safety of humans handling these products (animals can’t give themselves drugs)
-the safety of consuming food derived from treated animals (helps determine maximum residue limit)

18
Q

what is the regulatory agency of natural health products (NHP)?

A

-regulatory agency: Natural and non-prescription Health Products Directorate, Health Canada
-Natural Health Products regulations

19
Q

what are considered natural health products?

A

-vitamins and minerals
-herbal remedies
-homeopathic medicines
-traditional medicines such as traditional Chinese medicines
-probiotics
-other products, such as amino acids and essential fatty acids

20
Q

how do you buy natural health products?

A

-must be safe to use as over-the-counter products without a prescription
-if prescription is needed, the product should be regulated as drugs under the Food and Drug regulation

21
Q

what is the natural health products regulation in Canada?

A

-natural health products regulations
-product must have a product license (e.g. Natural Product Number-NPN)
-Canadian sites that manufacture, package, label and import must have site licenses
-specific labelling and packaging requirements must be met (cant make absurd claims)

22
Q

what are the labelling requirements in Canada?

A

-product name
-product license number
-quantity of the product in the bottle
-complete list of medicinal and non-medicinal ingredients
-recommended use (purpose or health claim, route of administration and dose)
-warnings, possible adverse reactions associated with the product
-storage conditions (if any)

23
Q

what must the manufacturer do when producing natural health products?

A

-good manufacturing practices (GMP) must be followed
-the manufacturer must provide full details on what the exact ingredients are, where they come from (source), the composition of any excipients (not active ingredients)
-proper safety and efficacy evidence must be provided

24
Q

what are the evidence requirements for safety and efficacy of natural health products? (claims)

A

depends on the proposed health claim of the product and its overall risks
-treatment claims: treatment or partial treatment and mitigation of a disease
-cure claims: describe a therapeutic effect that results in the elimination of a disease
-risk reduction claims: altering a major risk factor(s) for a disease or health-related condition
-prevention claims: significantly reduce the incidence of the disease
-general health maintenance: restoration, correction, or modification of a structure or physiological function in the human body
-antioxidant claims: antioxidant properties

25
Q

what are more evidence requirements for safety and efficacy?

A

-clinical trial data
-references to published studies, journals, pharmacopoeias and traditional resources

26
Q

how does adverse reaction reporting work for natural health products?

A

-product license holders are required to monitor all adverse reactions related to their product
-must report serious adverse reactions to Health Canada

27
Q

what is the regulatory agency of cosmetics?

A

-regulatory agency: healthy environments and consumer safety branch

-mandate to protect health by minimizing risks associated with the use of cosmetics
-defines and communicates requirements for manufacture, labelling, safe and evaluates compliance

Canada: cosmetic regulations under the Food and Drugs Act
-notification is a mandatory requirement (within 10 days of first sale), but not testing (put on market, notify Health Canada)

28
Q

what is the definition of a cosmetic?

A

“any substance or mixture of substances, manufactured, sold or represented for use inn cleansing, improving or altering the complexation, skin, hair, or teeth and includes deodorants and perfumes” Food and Drugs Act, Canada

-cosmetic products are required to have mandatory ingredient labelling as per the cosmetic regulations
-labelling should follow the international nomenclature for cosmetic ingredients (INCI) system

29
Q

what is an example of the quick INCI guide?

A

dont need to memorize

30
Q

what is the cosmetic ingredient hotlist (health canada)?

A

-communicates to manufacturers and others that certain substances may be prohibited or restricted for use in cosmetics
-a science-based document that is reviewed and updated periodically (i.e. when new scientific data becomes available)
-prohibited ingredients (should not be present in cosmetic products sold in Canada)
-restricted ingredients (are permitted under certain conditions, e.g. concentration)

31
Q

what is the cosmetic-drug interface?

A

-these are products that may share the characteristics of both “cosmetics” and “drug”
-examples: acne therapy, anti-perspirants, anti-dandruff products, fluoride-containing anti-caries products, medicated skin products, diaper rash products, antiseptic skin cleansers, sunburn protectants, skin whiteners, and tooth whiteners

32
Q

a product at the cosmetic-drug interface (PCDI) can be regulated by:

A

-the cosmetic regulations
-the food and drug regulations
-the natural health products regulations

33
Q

the distinction between drugs and cosmetics is based on:

A

-representations made about the products: what is the proposed claim?
-the composition of the product: ingredient and/or concentration may make the product unsuitable for classification as a cosmetic or as a drug
-level of action: does the product exert solely a superficial effect?

34
Q

what is the representations made about the product (drugs vs cosmetics)?

A

what is the proposed claim?
-if it is used for treating, diagnosing, preventing or curing disease; or restoring, correcting or modifying organic functions in human beings=drug

35
Q

what is the composition of the product (drug vs cosmetics)?

A

ingredient and/or concentration may make the product unsuitable for classification as a cosmetic or as a drug
-some ingredients are inherently drugs. For example, corticosteroids are internationally recognized as drugs (

36
Q

what is the level of action (drug vs cosmetics)?

A

does the product exert solely a superficial effect?
-cosmetics exhibit a lack of percutaneous absorption and should not have to be absorbed systematically to achieve the effect

37
Q

what is the graph of cosmetic-drug interface?

A
38
Q

what are some graphs of product type and if they are cosmetic, drug and NHP?

A